Pfizer and Sermo -- a Web-based community where physicians share observations from daily practice, discuss emerging trends and provide new insights into medications, devices and treatments -- recently announced a "strategic collaboration designed to redefine the way physicians in the U.S. and the healthcare industry work together to improve patient care."
To answer the many questions raised by this collaboration -- including concerns about off-label communications -- Pharma Marketing News invited Daniel Palestrant, M.D., founder and CEO of Sermo, to be a guest on a recent Pharma Marketing Talk podcast.
This article is based partly on that interview as well as other sources.
Topics and issues covered include:
- The Story of Sermo
- Doctors Are Lonely
- Sermo's Secret Sauce
- Sermo's Business Model
- From Contention to Collaboration
- Mining the Wisdom of the Sermo Crowd
- The Off-Label Promotion Issue
- Key Opinion Leaders
Read this article now. It's FREE...
Download PDF file